Kareem Saad - 01 Jan 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Chief Transformation Officer
Signature
/s/ Devin Schaffer, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
01 Jan 2024
Transactions value $
$0
Form type
4
Filing time
03 Jan 2024, 16:25:40 UTC
Previous filing
19 Dec 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $0 +273 +1.14% $0.00 24.2K 01 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Options Exercise $0 -273 -10.01% $0.00 2.46K 01 Jan 2024 Class A Common Stock 273 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 6.25% vest in quarterly installments over the 4-year period on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date